Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01993849 · ClinicalTrials.gov registry record · Phase 3
Use of N-Acetylcysteine (NAC) in Fingernail Biting
A Phase 3 study, sponsored by Kevin Gray, MD.
- Completed
- Registry status
- Phase 3
- Development phase
- 23
- Enrollment target
NCT01993849 is a Phase 3 study that has completed, run by Kevin Gray, MD. The registered enrollment target is 23 participants.
The verdict
NCT01993849, a Phase 3 study, has completed, sponsored by Kevin Gray, MD.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 23 participants
- Enrollment target
Study Summary
To conduct a pilot randomized placebo-controlled feasibility trial of N-acetylcysteine (NAC) in onychophagia, preliminarily assessing the tolerability and effects of this pharmacotherapy on young adults who bite their fingernails. It is proposed that NAC will help decrease fingernail biting.
Interventions
- OTHER Placebo
- DRUG N-Acetylcysteine (NAC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2013-10 |
| Est. Completion | 2015-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01993849
The ClinicalTrials.gov registry entry for NCT01993849 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kevin Gray, MD, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01993849 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01993849 about?
NCT01993849 is a clinical study titled "Use of N-Acetylcysteine (NAC) in Fingernail Biting". To conduct a pilot randomized placebo-controlled feasibility trial of N-acetylcysteine (NAC) in onychophagia, preliminarily assessing the tolerability and effects of this pharmacotherapy on young adults who bite their fingernails. It is proposed that NAC will help decrease fingernail biting.
What is the current status of trial NCT01993849?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 23 participants. The study started on 2013-10. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01993849?
The interventions under investigation include: Placebo (OTHER), N-Acetylcysteine (NAC) (DRUG).
Who is sponsoring clinical trial NCT01993849?
This trial is sponsored by Kevin Gray, MD, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.